Undervalued Small-Cap Healthcare Stocks on TSE September 2023

September 06, 2023

Healthcare Sector

The healthcare sector includes companies in biotechnology, pharmaceuticals, hospitals, home and long-term care. It also includes related medical equipment manufacturers and suppliers.

Toronto Stock Exchange

The Toronto Stock Exchange (TSE) is a stock exchange located in Toronto, Ontario, Canada. It is the 10th largest exchange in the world and the third largest in North America based on market capitalization.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Healthcare stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
TMD Titan Medical 0.17 0.46 172.26 55336 19 0.00 0.0
AH Aleafia Health 0.02 0.05 150.38 - 8 0.00 0.0
VPH Valeo Pharma 0.32 0.62 96.80 34908 26 0.00 0.0
CWEB Charlottes Web Holdings 0.42 0.80 90.62 99852 64 0.00 0.0
DN Delta 9 Cannabis 0.04 0.08 88.77 246853 6 0.00 0.0
AEZS AEterna Zentaris 3.48 6.54 87.95 574 17 0.00 0.0
ATE Antibe Therapeutics 0.57 1.05 83.46 20590 30 0.00 0.0
RVX Resverlogix 0.08 0.14 71.47 130778 22 0.00 0.0
CRRX CareRx 1.99 3.32 67.07 9864 126 0.00 0.0
ACB Aurora Cannabis 0.67 1.04 56.02 906306 235 0.00 0.0
All data provided as at market close September 04, 2023.

Company Details

Titan Medical

TMD:TSX

Close Price

0.17

Our Valuation

0.46

% Difference

172.26

Market Cap ($M)

19

P/E Ratio

0.0

Titan Medical Inc is in the research and development stage and is focused on the continued design and development of robotic-assisted surgical technologies for application in minimally invasive surgery including the development of the Enos robotic single-access surgical system.

Access the stockcalc valuation


Aleafia Health

AH:TSX

Close Price

0.02

Our Valuation

0.05

% Difference

150.38

Market Cap ($M)

8

P/E Ratio

0.0

Aleafia Health Inc is a vertically integrated cannabis health and wellness company which owns three cannabis product and cultivation facilities where it produces a diverse portfolio of commercially high-margin derivative products including oils, capsules and sprays. The company operates national network of medical cannabis clinics and has seen over 60,000 patients to date.

Access the stockcalc valuation


Valeo Pharma

VPH:TSX

Close Price

0.32

Our Valuation

0.62

% Difference

96.80

Market Cap ($M)

26

P/E Ratio

0.0

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Access the stockcalc valuation


Charlottes Web Holdings

CWEB:TSX

Close Price

0.42

Our Valuation

0.80

% Difference

90.62

Market Cap ($M)

64

P/E Ratio

0.0

Charlottes Web Holdings Inc is engaged in the production and distribution of hemp-based cannabidiol (CBD) wellness products. Its product categories include ingestible products (tinctures, capsules, and gummies), topicals, and pet products. The company distributes its products through an e-commerce website, third-party e-commerce websites, select distributors, health practitioners, and a variety of brick-and-mortar specialty retailers.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Delta 9 Cannabis

DN:TSX

Close Price

0.04

Our Valuation

0.08

% Difference

88.77

Market Cap ($M)

6

P/E Ratio

0.0

Delta 9 Cannabis Inc is a cannabis company. It sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. The company's subsidiary, Delta 9 Bio-Tech Inc, is a licensed producer of medical and recreational cannabis and operates an 80,000-square-foot production facility in Winnipeg, Manitoba, Canada. The company owns and operates a chain of retail stores under the Delta 9 Cannabis store brand.

Access the stockcalc valuation


AEterna Zentaris

AEZS:TSX

Close Price

3.48

Our Valuation

6.54

% Difference

87.95

Market Cap ($M)

17

P/E Ratio

0.0

AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada.

Access the stockcalc valuation


Antibe Therapeutics

ATE:TSX

Close Price

0.57

Our Valuation

1.05

% Difference

83.46

Market Cap ($M)

30

P/E Ratio

0.0

Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions. The company's pipeline includes assets that seek to overcome gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs. Antibe's lead drug, otenaproxesul, is in clinical development as a safer alternative to opioids for post-operative pain.

Access the stockcalc valuation


Resverlogix

RVX:TSX

Close Price

0.08

Our Valuation

0.14

% Difference

71.47

Market Cap ($M)

22

P/E Ratio

0.0

Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins.

Access the stockcalc valuation


CareRx

CRRX:TSX

Close Price

1.99

Our Valuation

3.32

% Difference

67.07

Market Cap ($M)

126

P/E Ratio

0.0

CareRx Corp is a provider of specialty pharmacy services to seniors. The company is a national organization with a large network of pharmacy fulfilment centers strategically located across the country. This allows it to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. It takes an active role in working with its home operator partners to promote resident health, staff education, and medication system quality and efficiency.

Access the stockcalc valuation


Aurora Cannabis

ACB:TSX

Close Price

0.67

Our Valuation

1.04

% Difference

56.02

Market Cap ($M)

235

P/E Ratio

0.0

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Titan Medical and Aleafia Health are the most undervalued Small-Cap Healthcare stocks on the TSE. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tse-september-2023
Titan Medical $TMD and Aleafia Health $AH are the most undervalued Healthcare stocks on the #TSE. See the full list: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tse-september-2023
Titan Medical and Aleafia Health are the most undervalued Small-Cap Healthcare stocks on the TSE. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tse-september-2023

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.